Veru (VERU)
(Delayed Data from NSDQ)
$1.21 USD
-0.11 (-8.33%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $1.22 +0.01 (0.83%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
Price, Consensus and EPS Surprise
VERU 1.21 -0.11(-8.33%)
Will VERU be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for VERU based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for VERU
What Makes Veru (VERU) a New Buy Stock
After Plunging -15.61% in 4 Weeks, Here's Why the Trend Might Reverse for Veru Inc. (VERU)
VERU: What are Zacks experts saying now?
Zacks Private Portfolio Services
Bio-Rad Laboratories (BIO) to Post Q4 Earnings: What Awaits?
Charles River (CRL) to Report Q4 Earnings: What's in Store?
Veru Inc. (VERU) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Other News for VERU
Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11
LI, VERU and MRIN among pre-market losers
Veru, EyePoint Pharmaceuticals, Sintx Technologies among healthcare movers
Veru, EyePoint Pharmaceuticals, SINTX Technologies among healthcare movers
Truist healthcare analyst to hold an analyst/industry conference call